Benzophenone-2 exerts reproductive toxicity in male rats.

Benzophenone-2 Benzophenones Reproductive toxicity Sex hormone Testes inflammation Testicular macrophages

Journal

Reproductive toxicology (Elmsford, N.Y.)
ISSN: 1873-1708
Titre abrégé: Reprod Toxicol
Pays: United States
ID NLM: 8803591

Informations de publication

Date de publication:
09 2023
Historique:
received: 13 03 2023
revised: 25 07 2023
accepted: 29 07 2023
medline: 28 8 2023
pubmed: 6 8 2023
entrez: 5 8 2023
Statut: ppublish

Résumé

Benzophenone derivatives such as benzophenone-2 (BP-2) belong to the group of endocrine disrupting compounds (EDCs). Increased exposure to EDCs is considered to be an important factor behind the decline of human fertility. The main aim of the present study was to determine the effect of BP-2 on testicular function specified by sperm analysis, the level of sex hormones and their receptors. Since BP-2 has been shown to activate the immune system, another aim of the research was to verify the hypothesis that the immune system may be contributing to the testis toxicity of this compound and for this purpose changes in macrophage and lymphocyte populations in the testes were determined. BP-2 at a dose of 100 mg/kg was administered dermally, twice daily at a dose of 100 mg/kg for 4-weeks. It was shown that BP-2 reduced the number and motility of sperm and increased the number of sperm showing morphological changes. By determining the concentration of sex hormones, a significant decrease in testosterone levels and an increase in the blood levels of 17β-estradiol were demonstrated. Similar to the results obtained from the blood samples, testosterone levels in the testes were lowered, which could affect sperm parameters. The effect of BP-2 on lowering testosterone levels and the number of sperm cells may be due to immunoactivation in the testes, because it has been detected that this compound significantly decreased the number of the immunosuppressive resident testicular macrophages (TMs) (CD68

Identifiants

pubmed: 37543253
pii: S0890-6238(23)00124-7
doi: 10.1016/j.reprotox.2023.108450
pii:
doi:

Substances chimiques

2,2',4,4'-tetrahydroxybenzophenone PRR8K3H9VN
Gonadal Steroid Hormones 0
Benzophenones 0
Testosterone 3XMK78S47O

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

108450

Informations de copyright

Copyright © 2023 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Zaneta Broniowska reports financial support was provided by National Science Centre Poland.

Auteurs

Żaneta Broniowska (Ż)

Department of Biochemical Toxicology Medical College, Jagiellonian University, Medyczna 9, 30-688 Kraków, PL, Poland. Electronic address: zaneta.broniowska@uj.edu.pl.

Igor Tomczyk (I)

Department of Genetics and Evolution, Institute of Zoology and Biomedical Research, Jagiellonian University, Krakow, Poland.

Paweł Grzmil (P)

Department of Genetics and Evolution, Institute of Zoology and Biomedical Research, Jagiellonian University, Krakow, Poland.

Beata Bystrowska (B)

Department of Biochemical Toxicology Medical College, Jagiellonian University, Medyczna 9, 30-688 Kraków, PL, Poland.

Alicja Skórkowska (A)

Department of Biochemical Toxicology Medical College, Jagiellonian University, Medyczna 9, 30-688 Kraków, PL, Poland.

Alicja Maciejska (A)

Department of Biochemical Toxicology Medical College, Jagiellonian University, Medyczna 9, 30-688 Kraków, PL, Poland.

Grzegorz Kazek (G)

Department of Pharmacodynamics, Medical College, Jagiellonian University, Medyczna 9, 30-688 Krakow, Poland.

Bogusława Budziszewska (B)

Department of Biochemical Toxicology Medical College, Jagiellonian University, Medyczna 9, 30-688 Kraków, PL, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH